The effects of selected probiotic strains on the development of eczema (the PandA study)

L Niers1, R Martín, G Rijkers

  • 1Department of Pediatrics, Wilhelmina Children's' Hospital, University Medical Center, Utrecht, the Netherlands.

Allergy
|April 28, 2009
PubMed

Insights

Probiotic supplementation with Bifidobacterium bifidum, Bifidobacterium lactis, and Lactococcus lactis reduced eczema incidence in high-risk infants. The preventive effect on eczema was observed within the first 3 months and sustained for 2 years.

Area of Science:

  • Microbiology and Immunology
  • Pediatric Allergy and Dermatology

Background:

  • Intestinal microbiota modulation via probiotics is a potential strategy for preventing allergic diseases.
  • High-risk infants (positive family history of allergy) were studied for primary prevention of allergic disease.

Purpose of the Study:

  • To investigate the efficacy of pre- and postnatal probiotic supplementation in preventing allergic disease in high-risk children.
  • To assess the impact of a specific probiotic mixture on eczema incidence and related immune markers.

Main Methods:

  • A double-blind, randomized, placebo-controlled trial was conducted.
  • Mothers of high-risk children received a probiotic mixture (Bifidobacterium bifidum, Bifidobacterium lactis, Lactococcus lactis) prenatally and their offspring for the first 12 months.
  • Parental reports and in vitro immune responses were monitored.

Main Results:

  • Eczema incidence was significantly lower in the probiotic group during the first 3 months (6/50 vs 15/52, P=0.035).
  • Eczema incidence became similar after 3 months, but cumulative incidence remained lower in the intervention group at 1 and 2 years.
  • The probiotic group showed increased Lactococcus lactis colonization and decreased IL-5 production at 3 months.

Conclusions:

  • This probiotic combination demonstrates a preventive effect on eczema in high-risk children.
  • The preventive effect is established early, within the first 3 months, and sustained for up to 2 years.
  • Probiotic-induced changes in Lc. lactis colonization and IL-5 production may contribute to eczema prevention.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...